Nxera Pharma Co Ltd (SOLTF) Q2 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

We will now begin the webinar on the Sosei Group financial results for the second quarter of fiscal year 2022. Thank you very much for taking time out of your busy schedule to join us today. I am Nomura, CFO, and I will be the moderator for this session. Chris Cargill, CEO, and Matt Burns, President of Heptares and UK Head of Research and Development, are attending today. Simultaneous translation will be provided. Please select either Japanese or English by clicking on the globe icon in the lower right corner of the screen. If you choose off, you will hear the speaker's original voice. Today, we will present the progress of our business with the materials in the first half, followed by a question and answer session in the second half. The presentation materials will be shared on the screen. They are also available on our website. If you would like to obtain a copy of the materials, please click on the shareholder investor relations tab in the upper right corner of our company homepage and select the presentation materials. and video to access the materials. For questions, institutional investors, analysts, and the media will be requested to raise their hands in the Q&A session. All other participants are requested to submit their questions by clicking on the Q&A button. You may submit your question at any time during the webinar. You will answer as the time permits during the Q&A session in the second half of the session. If you are going to ask any questions, please Try to install the app and then join the winner because sometimes the browser based have some technical problems. Now we will now move on to the presentation. First, I will give you an update on the financial results for the first half of the year, followed by a novel business update from CEO Chris. and ...